Global Spice Oils and Oleoresins Market: Key Drivers and Future Forecast

Spice Oils and Oleoresins Market
Spice Oils and Oleoresins Market

According to Future Market Insights (FMI), the spice oils and oleoresins market may reach an overall valuation that is expected to surpass US$ 1,674.40 million in 2023. The market is expected to record a CAGR of 7.9% between 2023 and 2033. By 2033, the market is estimated to reach a valuation of US$ 3,567.2 million.

Significant Aspects Driving the Growth of the Market:

  • Oleoresins are used to create aromas, fragrances, and various cosmetic items. They are ideal for creating hair loss lotion, cologne, perfumes, and other cosmetics due to their consistency, texture, and fragrances.
  • They have multiple uses as they are considered anti-inflammatory, antioxidant, and used for treating cancer. Hence they are utilized in the pharmaceutical sector as a component of medications, medicinal soaps, and other products. Thus, these factors are expected to drive the growth of the market for cosmetics and medicines.
  • Analgesic properties of chili oleoresins help in the reduction of free radicals in the body thus making them useful in medicinal applications. Over the course of the projection period, the market is projected to be driven by all these important aspects.
  • The expanding consumption of organic foods and beverages has raised the need for organic spices, such as natural spice oils, oleoresins products, etc. The spice oils market and the oleoresins market are expected to experience significant growth in the coming years.
  • Sales of plant-based snacks, dips, spreads, sauces, creamers, cheese, and other foods and beverages are rising as consumers prefer the taste of spice oil as well as they are also interested in clean-label and vegan products. Thus, creating multiple prospects for the market.

Key Takeaways from Market Study

  • The spice oils and oleoresins market is expected to reach an overall valuation of US$ 1,674.40 million in 2023.
  • The spice oil and oleoresin market in Germany is expected to record a CAGR of 7%
  • The spice oil and oleoresin market in China is expected to reach a valuation of US$ 567.18 million by 2033. The market is expected to record a CAGR of 7% over the forecast period.
  • The spice oil and oleoresin market in Spain is expected to record a CAGR of 5.4%

Competitive Landscape:

Companies look for inorganic growth strategies, such as alliances, global expansion, and mergers and acquisitions, in order to maintain a competitive position in the market. Major players in the global spice oil and oleoresin market are concentrating on launching cutting-edge goods that meet the needs of consumers in order to increase their operational presence in various regions of the world.

Some of the Key Players in the Spice Oil and Oleoresin are:

  • Young Living Essential Oils Ltd.
  • Reckitt Benckiser Group Plc (RB)
  • Symrise AG
  • Givaduan AG
  • Greenleaf Extractions Pvt. Ltd.
  • Indian Spice Oil Industries
  • Synthite Industries Ltd.
  • Universal Oleoresins Pvt. Ltd.

Recent Developments:

  • The well-known Dutch oil company Ultra International B.V. operates in important regions and has offices in Singapore, the United States, Australia, India, and the Middle East. The company uses medicinal plants including eucalyptus, coriander, cumin, and cloves to create various kinds of oils.
  • A well-known producer of essential oils, DoTERRA International LLC, entered the South American market in September 2019. The company produced therapeutic essential oils using oleoresin. This innovation has made the best medicinal oils that are easily accessible to customers in South America.

Key Segments

Product Type:

  • Spice Oils
  • Oleoresins

Distribution Channel:

  • B2B/Direct
  • B2C/Indirect

Nature:

  • Organic
  • Conventional

Application:

  • Food & Beverages
  • Bakery & Confectionery
  • Beverages
  • Dressings & Condiments
  • Sauces, Spreads & Soups
  • Cosmetics and Personal Care
  • Skin Care
  • Hair Care
  • Toiletries.
  • Aromatherapy
  • Pharmaceuticals
  • Household
  • Dietary Supplements
  • Foodservice
  • Industrial

Region:

  • North America (United States & Canada)
  • Latin America (Mexico, Brazil, Peru, Argentina & Rest of Latin America)
  • Europe (EU-4, BENELUX, Nordic Countries, Russia, Poland & Rest of Europe)
  • South Asia (India, Thailand, Indonesia, Malaysia, and Rest of South Asia)
  • East Asia (China, Japan & South Korea)
  • Oceania (Australia & New Zealand)
  • Middle East & Africa (GCC, Northern Africa, South Africa & Rest of MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Yellow Pea Protein Market Analysis: Growth Trajectory and Trends Through 2033

Yellow Pea Protein Market

The yellow pea protein market is predicted to capture a valuation of USD 3.3 billion in 2023 and is projected to rise to USD 11.5 billion by 2033. As per the FMI report, the market is likely to register a CAGR of 14.4% during the forecast period.

Food & beverage manufacturers are developing nutrition supplements by increasing the adoption of yellow pea protein, such as energy drinks and smoothies. The rising consumer demand for vegan, high-fiber, clean-label, and non-toxic food products is surging market growth. In addition, growing awareness related to health and rising cardiovascular diseases is rapidly increasing yellow pea protein nutrition.

Increasing disposable income, urbanization, population, and changing eating habits fuel market opportunities. Manufacturers are developing food & beverage products by adopting advanced technology and adding natural ingredients. In addition to that, it enhanced the shelf-life of food and improved quality by adding vegan ingredients surging the product demand globally. Growing consumer demand for food items such as plant-based milk, vegan burger, milkshakes, and supplements drive the yellow pea protein market.

Social media influencers, athletes, and famous personalities promote top companies’ brands to make people aware customers of healthy diets. The yellow pea protein is the better alternative source that reduces weight and cholesterol and promotes a healthy heart. However, people cannot maintain their healthy lifestyles due to hectic lifestyles. Therefore, plant-based protein producers develop packed supplements to provide proper healthy nutrition to their consumers.

High Cost of Yellow Pea Protein Limits the Market Growth

The market is promoting a healthy lifestyle by increasing the production of plant-based products. However, key manufacturers faced certain roadblocks that declined the market growth, which included the increasing cost of yellow pea protein supplements and Isolates restraining the market growth.

The low availability of plant-based raw materials and alternate substitutes limits the market growth. Moreover, a few consumers suffer from lactose intolerance hinders the market.

Key Takeaways:

  • The yellow pea protein market is expected to have a valuation of US$ 11.5 billion by 2033.
  • With a CAGR of 14.4%, the global market is increasing during the forecast period.
  • The market in the United States is anticipated to capture a CAGR of 8.9% through 2033.
  • With a CAGR of 11.6%, the United Kingdom yellow pea protein market significantly uplifts during the forecast period.
  • German market is expected to secure a CAGR of 9.8% over the forecast period.
  • China market is capturing a CAGR of 13.2% by 2033.

Who is Winning?

The key players play a vital role in the global market by capturing maximum revenue by investing their amount in research and development activities. In addition, these players are focusing on developing better quality products per consumers’ requirements.

The prominent players innovate plant-based products to promote a healthy lifestyle by adopting several marketing methodologies. Marketing strategies adopted by these players are collaborations, mergers, partnerships, product launches, and acquisitions.

Other Prominent Players in the Market are:

  • Cargill Inc.
  • DuPont de Nemours, Inc.
  • The Scoular Company
  • Axiom Foods, Inc.
  • Glanbia Ple
  • Roquette Frères
  • Kerry Group PLC
  • Bata Food
  • Shandong ianyan Group
  • The Green Lab LLC
  • Puris Proteins LLC
  • Burcon NutraScience Corporation
  • Cosucra Groupe Warcoing S.A.

Recent Developments in the Market are:

  • In 2018, Axiom Foods announced its new distributor Univar Solutions, to supply goods & services of plant-based ingredients.
  • In 2021, Puris Proteins LLC announced a newly launched plant for manufacturing yellow pea protein to upsurge its business in the United States.
  • In February 2018, DuPont de Nemours Inc announced its launch of BAIC (Bay Area Innovation Center) to upsurge agricultural biotechnology and technological development.

Yellow Pea Protein Market by Category

By Product Type:

  • Protein Concentrates
  • Protein Isolates
  • Textured Protein
  • Hydrolyzed Protein

Processing Type:

  • Dry Processing
  • Wet Processing

End Use:

  • Food Processing
  • Meat Alternatives
  • Bakery Products
  • Confectionery
  • Snacks & Cereals
  • Meat-based Products
  • Functional Beverages
  • Others
  • Animal Feed
  • Nutraceuticals
  • Sports Nutrition
  • Infant Nutrition
  • Cosmetic & Personal Care

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Migraine Treatment Market Poised for Robust Growth, Projected to Reach USD 4.74 Billion by 2033

The global migraine treatment market is set to witness significant expansion, with projections estimating a market value of USD 3.2 billion in 2023, climbing to an impressive USD 4.74 billion by 2033. This growth trajectory reflects a Compound Annual Growth Rate (CAGR) of 4% over the forecast period of 2023 to 2033. Historically, the market demonstrated a steady CAGR of 3% from 2018 to 2022.

Meeting the Growing Demand for Migraine Management:

The Migraine Treatment market represents a crucial segment of the healthcare industry, addressing a condition that affects millions globally. The market encompasses a diverse portfolio of products and services aimed at managing migraine symptoms effectively. Key offerings include:

  • Medications: Over-the-counter pain relievers such as aspirin and ibuprofen.
  • Lifestyle Modifications: Strategies like maintaining a consistent sleep schedule, avoiding triggers, and engaging in stress-relief activities like exercise or meditation.
  • Advanced Therapies: Neuromodulation devices, cognitive-behavioral therapy (CBT), acupuncture, and nutritional supplements.

This comprehensive approach underscores the industry’s commitment to improving patient quality of life and managing the complexities of migraine treatment.

Drivers of Market Growth:

Several factors contribute to the positive outlook for the Migraine Treatment market:

  1. Increasing Prevalence: Rising awareness of migraine and its management options has led to higher diagnosis rates, driving market demand.
  2. Technological Advancements: Innovations in neuromodulation devices and non-invasive therapies are broadening treatment options.
  3. Lifestyle Awareness: Growing emphasis on holistic health, including stress management and nutrition, complements traditional medication.

Enhanced Market Demand! Discover Thorough Trends and Insights in Our Complete Report!

Future Outlook:

As the burden of migraines continues to impact individuals and healthcare systems worldwide, the demand for effective and innovative treatment solutions will only grow. Market stakeholders are focusing on R&D investments to develop advanced therapies, ensuring enhanced efficacy and patient compliance.

With steady growth and evolving treatment modalities, the Migraine Treatment market stands as a vital contributor to the healthcare industry, poised to make a lasting impact on millions of lives.

Key Takeaways from the Market Study:

  • From 2018 to 2022, the migraine treatments market grew at a CAGR of 3%.
  • The global migraine treatments market is expected to grow with a 4% CAGR during 2023 to 2033.
  • As of 2033, the migraine treatments Market is expected to reach USD 4.74 Billion.
  • According to the FMI analysis, hospitals account for the largest market share.
  • North America is expected to possess 40% market share for the migraine treatments market.
  • The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering migraine treatments.” says an FMI analyst

Market Competition:

Key players in the market include companies such as Voyager Therapeutics, Spark Therapeutics, Novartis AG, Bluebird bio, Inc., Biogen, Pfizer Inc., Rapa Therapeutics, BrainStorm Cell Therapeutics, Eli Lilly and Company, and UniQure Biopharma, along with healthcare providers and technology companies among other global players.

  • In November 2022, A team of researchers at University College London (UCL) developed a novel gene therapy that offers promise in treating neurological and psychiatric disorders. The therapy targets overactive brain cells that are responsible for causing several brain diseases, including epilepsy, by reducing their excitability. By using DNA sequences that control gene expression, the therapy drives the production of molecules that prevent these overactive cells from firing, thereby curbing epileptic seizures. Notably, the technique selectively alters only overactive cells while sparing normally functioning cells.
  • In preclinical studies, the new treatment demonstrated a higher efficacy than previous gene therapies or anti-seizure drugs tested in the same model. The team observed an approximately 80% reduction in spontaneous seizures in epileptic mice treated with the therapy. Furthermore, the researchers believe that this gene therapy has the potential to treat other disorders where some brain cells are overactive, such as Parkinson’s disease.

Key Segments Profiled in the Migraine Treatment Industry Survey:

Drug Class:

  • Zavegepant
  • Atogepant
  • Zolmitriptan

Route of Administration:

  • Oral
  • Parenteral
  • Nasal Sprays

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Treatment:

  • Abortive Medicine
  • Preventive Medicine

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Hepatic Encephalopathy Treatment Market on a Robust Growth Trajectory: Expected to Reach USD 2971.51 Million by 2033

The global hepatic encephalopathy treatment market is set to achieve significant growth, with projections indicating an increase from USD 1583 Million in 2023 to USD 2971.51 Million by 2033, reflecting a CAGR of 6.5% during the forecast period. The market witnessed a moderate growth rate of 3.9% CAGR during the historical period of 2018 to 2022, which is now accelerating due to a surge in liver-related disorders worldwide.

Key Market Drivers:

The rise in liver diseases, including cirrhosis and non-alcoholic fatty liver disease (NAFLD), is a primary factor fueling market growth. As hepatic encephalopathy stems from the liver’s inability to eliminate toxins from the bloodstream effectively, leading to toxin buildup in the brain, the demand for comprehensive treatment solutions continues to grow.

Understanding Hepatic Encephalopathy:

Hepatic encephalopathy is a severe condition that can range from mild to life-threatening, characterized by symptoms such as:

  • Cognitive dysfunction: Confusion and personality changes.
  • Neurological issues: Tremors and loss of motor control.
  • Severe outcomes: Potential progression to coma in advanced stages.

Effective management of HE involves addressing its root causes, primarily liver diseases like cirrhosis. Treatments include:

  • Medication: To reduce toxin levels in the bloodstream.
  • Dietary modifications: Tailored to support liver health.
  • Lifestyle changes: Including alcohol cessation and regular medical monitoring.

Future Outlook:

With advancements in medical research and increased awareness, the HE treatment market is poised for steady growth. Pharmaceutical innovations and comprehensive management strategies targeting liver health will play a critical role in shaping the market landscape.

As the prevalence of liver disorders continues to rise, so does the importance of effective hepatic encephalopathy treatments. The robust growth projected for the global HE treatment market underscores the urgency and potential for innovation in managing this critical condition, paving the way for improved patient outcomes and a healthier global population.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Key Takeaways from the Market Study:

  • The Hepatic encephalopathy treatment market is expected to grow at a value of 6.5% CAGR in the forecast period 2023-2033
  • Hospital pharmacies are expected to hold 49% of the market share in 2023 for Hepatic encephalopathy treatment market.
  • North America is expected to possess 44% market share for Hepatic encephalopathy treatment market in 2023.
  • Asia Pacific Hepatic encephalopathy treatment market size is expected to possess 39% market share in 2023.

“The Hepatic Encephalopathy Treatment Market is also being driven by the increasing adoption of combination therapies for HE.” states an FMI analyst

Competitive Landscape:

Key players in the hepatic encephalopathy treatment market are Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services, Takeda Pharmaceutical Company Limited, Merck & Co., Inc.

  • Mallinckrodt Pharmaceuticals has developed and marketed several medications for the treatment of Hepatic Encephalopathy that include Ofirmev and Terlipressin (Glypressin) injection. In addition to these medications, Mallinckrodt Pharmaceuticals has also sponsored clinical research into the treatment of HE, with a focus on developing new treatments and improving the understanding of the condition.
  • Salix Pharmaceuticals has developed Xifaxan (rifaximin) tablets. Xifaxan is an antibiotic medication that works by reducing the levels of bacteria in the gut, which can help reduce the production of toxins that contribute to the development of HE.

Key Segments Profiled in the Hepatic Encephalopathy Treatment Industry Survey

Drug Class:

  • Antibiotics
  • Laxatives
  • L-ornithine
  • L-aspartate

Diagnosis:

  • Blood Tests
  • CT Scan
  • Liver Functioning Tests

Route of Administration:

  • Oral
  • Injectable
  • Intravenous
  • Others

Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global GLP-1 Receptor Agonist Market Set for Exceptional Growth: Projected to Surge USD 72,127.79 Million by 2034 grow at a CAGR of 11.7%

The global GLP-1 receptor agonist market is poised for extraordinary expansion, driven by an increase in therapeutic applications and favorable market projections. Recent analysis indicates a promising trajectory, with expectations for the market to grow from USD 23,854.53 million in 2024 to an impressive USD 72,127.79 million by 2034. This meteoric rise reflects a robust Compound Annual Growth Rate (CAGR) of 11.7%, establishing the market as a dynamic and high-growth sector within the pharmaceutical industry.

GLP-1 receptor agonists are essential in managing type 2 diabetes and various metabolic disorders. Their growing effectiveness in glycemic control and weight management is garnering significant attention, and expanding therapeutic applications are further propelling market growth. This expansion is supported by ongoing research and development efforts that are advancing these life-changing therapies.

Key Drivers of Market Growth:

  1. Increased Prevalence of Type 2 Diabetes: The rising global incidence of type 2 diabetes is a major catalyst for demand for effective management solutions, notably GLP-1 receptor agonists.
  2. Advancements in Drug Formulations: Continuous innovations in drug delivery systems and formulations are enhancing the therapeutic profiles of GLP-1 receptor agonists, broadening their clinical applications.
  3. Growing Patient Awareness and Accessibility: Increased awareness among patients and improved access to healthcare services are facilitating the greater adoption of GLP-1 receptor agonists across diverse demographics.
  4. Supportive Regulatory Environment: Favorable regulatory policies and expedited approval processes are creating a conducive environment for the development and commercialization of new GLP-1 receptor agonist therapies.

The projected growth trajectory of the GLP-1 receptor agonist market underscores its potential to address unmet medical needs and transform patient outcomes. Stakeholders across the industry, including pharmaceutical companies, healthcare providers, and investors, stand to benefit from this dynamic expansion and the evolving opportunities it presents.

Key Takeaways from the Market Study:

  • Type-2 Diabetes dominates the GLP-1 receptor agonist market by indication, accounting for a share of 75.00%.
  • Hospital pharmacies lead the distribution channel in the GLP-1 receptor agonist industry, accounting for a 34.00 % market share.
  • The GLP-1 receptor agonist market in India has the potential to increase at 24.70% CAGR through 2034.
  • The market in China is anticipated to develop at a CAGR of 23.10 % through 2034.
  • The market in the United Kingdom is predicted to rise at a CAGR of 12.10% through 2034.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Competitive Landscape:

Pharmaceutical companies use various strategies for market expansion. These include conducting clinical trials to broaden the indications for existing products and targeting additional disease areas such as obesity and NAFLD. They are also developing innovative formulations and delivery systems to improve patient convenience and adherence.

Companies are investing in marketing and educational initiatives to raise awareness among healthcare professionals and patients about the benefits of GLP-1 receptor agonists in diabetes management.

Recent Developments:

  • Eli Lilly introduced Orforglipron in June 2023, which could revolutionize treatment options for obesity and type 2 diabetes.
  • In October 2023, researchers created chimeric GLP-1 receptor agonists that show promise as long-lasting treatments for type 2 diabetes.
  • In November 2023, researchers developed a groundbreaking long-acting GLP-1 agonist that could offer promising advancements in diabetes management.
  • In August 2023, GLP-1 medications like Ozempic, Wegovy, and Mounjaro reshaped the pharmaceutical landscape by curbing appetites and triggering significant weight loss.

Key Companies in the Market:

  • Eli Lilly and Company
  • Sanofi
  • Novo-Nordisk A/S
  • AstraZeneca
  • Pfizer.Inc
  • Amgen, Inc.
  • Innovent Biologics, Inc.
  • PegBio Co., Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH

Key Market Segmentation:

By Drug Class:

  • Exenatide
  • Liraglutide
  • Dulaglutide
  • Lixisenatide
  • Others

By Route of Administration:

  • Parenteral
  • Oral

By Indication:

  • Diabetes
  • Cardiovascular Disease
  • Weight Management
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Clinics
  • Ambulatory Surgical Centres

By Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East & Africa
  • Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Artificial Tears Market Poised for Remarkable Growth, Expected to Reach USD 5.8 Billion by 2034 expand at a CAGR of 5.4%

The global artificial tears market is set to experience robust growth in the coming years, with a projected valuation of USD 3.4 billion in 2024, expanding at a compound annual growth rate (CAGR) of 5.4% to reach an impressive USD 5.8 billion by 2034, according to a recent report by Future Market Insights.

The healthcare industry is experiencing significant changes to develop a robust system to improve eye care.  Nanomicellular technology is a strong system used in artificial tears production. These are utilized as pharmaceutical carriers for dissolving hydrophobic medications.

Substances like povidone simulate mucin’s function, tears’ adhesion to the ocular surface, and the component of the inner tear. Due to prolonged exposure to blue light emitted from digital screens, higher use of mobile phones, rising pollution levels, and dry weather spells, there has been a significant increase in dry eye symptoms among persons in their teens and 20s during the past five years.

“Increasing strategic activities among key players and rising focus toward developing new artificial tears are expected to witness an advancement over the forecast period.”, says an analyst of FMI.

Key Takeaways from the Market Study:

  • Glycerine tears are the leading segment of artificial tears and will hold around 4% market value share in 2024; glycerine eyes reduce the burning, itching, and feeling that something is in the eyes associated with dry eyes.
  • The solution is set to lead in terms of the dosage form of artificial tears with a projected market value share of around 2% by 2034.
  • By formulation, non-preservative-based is leading in the global artificial tears market and is expected to continue to do so with a projected CAGR of 6% during the forecasted years with a market share of 55.2% in the year 2024.
  • Dry eye syndrome holds a substantial share of 2% in the artificial tears market, with a CAGR of 5.4% during the forecast period. Dry eye syndrome is a multifactorial ocular surface disease brought on by a breakdown in the tear film’s equilibrium.
  • Retail pharmacies as a distribution channel are leading in the global artificial tears market. They are expected to continue to do so with a projected CAGR rate of 6% during the forecast years, with a market share of 38.0% in 2024.
  • North America is the leading region with a value share of 9% in 2024, owing to the high prevalence of ocular problems such as eye allergies.

Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!

Market Competition:

The market for artificial tears is fragmented, and several local, upcoming, and established players exist within the market. Key players have initiated marketing initiatives to educate the elderly population about the benefits of artificial tears while also attempting to improve the drugs with different specifications.

  • On 7 October 2019, Allergan plc announced three new over-the-counter (OTC) products: REFRESH RELIEVA, REFRESH RELIEVA PF (preservative-free) multidose, and REFRESH RELIEVA, respectively. This new line of artificial tear formulations is intended for contact lens wearers and was developed to reduce discomfort caused by eye dryness and to stop irritation.
  • On 5 November 2022, I-MED Pharma announced the launch of an innovative dry eye product portfolio in the United States. A company that offers a wide range of products, such as I-DROP artificial tears and I-LID ‘N LASH ocular hygiene cleaners.

Key Players in the Artificial Tears Market:

  • AbbVie, Inc.
  • Akorn, Inc.
  • Alcon
  • Bausch & Lomb
  • Johnson & Johnson
  • Eyevance Pharmaceuticals LLC
  • Ocusoft
  • I- MED PHARMA
  • Santen Pharmaceutical Co. Ltd
  • Similasan Corporation
  • Sun Pharmaceutical Industries Ltd
  • Ursapharm Arzneimittel GmbH
  • Novartis International AG
  • AFT Pharmaceuticals

Key Segments Covered in Artificial Tears Market:

By Product Type:

  • Glycerine Tears
  • Cellulose Tears
  • Oil-based Emulsion Tears
  • Polyethylene Glycol-based Tears
  • Sodium Hyaluronate Based Artificial Tears
  • Propylene Glycol-based Tears

By Dosage Form:

  • Solution
  • Ointment
  • Emulsion
  • Gel
  • Spray
  • Suspensions

By Formulation:

  • Preservative Based
  • Non-Preservative Based

By Indication:

  • Dry Eye Syndrome
  • Allergies
  • Infections
  • UV & Blue Light Protection
  • Contact Lens Moisture Retention
  • Others

By Distribution channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Ophthalmic Stores

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Veterinary Endoscope Market Set for Robust Growth: Projected Value to Reach USD 625.3 Million by 2034 at a CAGR of 8.10%

The global veterinary endoscope market is on the rise, with estimated sales valued at USD 286.9 million in 2024, and projections indicating a significant increase to USD 625.3 million by 2034. This growth reflects a robust compound annual growth rate (CAGR) of 8.10% throughout the forecast period from 2024 to 2034.

In 2023, the veterinary endoscope industry generated USD 265.4 million, and sales are expected to show a year-on-year growth of 8.10% in 2024. This upward trajectory is driven by the growing preference for minimally invasive diagnostic and surgical procedures in veterinary practices.

Veterinary endoscopes play a crucial role in diagnosing and conducting minimal surgeries on pets, providing a less painful alternative to traditional open surgeries. The adoption of endoscopic procedures has soared due to their associated benefits, including reduced pain and quicker recovery times for animals.

The market is categorized by various procedure types, with gastrointestinal endoscopy leading the sector, capturing 43.2% of the market share, closely followed by arthroscopy. Notably, the diagnosis segment has significantly contributed to revenue growth, accounting for 69.3% of total earnings. These versatile endoscopes cater to both large and small animals and can be designed in rigid, flexible, or other forms.

As veterinary practices increasingly embrace advanced technologies, the demand for veterinary endoscopes is expected to grow, enhancing the quality of care for pets and contributing to the overall health of animals worldwide.

Key Takeaways:

  • The global sales of veterinary endoscopes are estimated to be worth USD 286.9 million in 2024.
  • The industry is anticipated to exhibit a year-over-year (Y-o-Y) growth of 8.10% in 2024.
  • The global sales of veterinary endoscopes are anticipated to reach a value of USD 625.3 million by 2034.
  • Sales are projected to rise at a Compound Annual Growth Rate (CAGR) of 8.10% over the forecast period between 2024 and 2034.
  • With an expected CAGR of 8.1%, China is projected to have the highest growth rate among the listed countries.
  • Following closely behind, South Korea is anticipated to experience a CAGR of 6.4%.
  • Canada is expected to have a moderate growth rate of 4.4%.
  • France is projected to have a similar growth rate of 4.1%.
  • Italy is expected to have a slightly lower growth rate of 3.7%.
  • Japan is projected to have a lower growth rate of 3.3%.
  • Germany is expected to have the lowest growth rate among the listed countries, at 2.5%.

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Competitive Landscape:

Key players in the veterinary endoscopes market are actively investing in the development of innovative endoscope technologies. Many companies are employing strategies such as mergers and acquisitions to enhance their market presence and expand operations. Additionally, market participants are collaborating with others along the value chain to improve patient care.

Recent Developments in the Veterinary Endoscopes Market

  • June 2024: Asensus Surgical, Inc. and Karl Storz Endoscopy-America, Inc. announced a merger agreement, with Karl Storz expected to acquire all outstanding shares of Asensus Surgical for USD 0.35 per share in cash.
  • November 2022: OmniVision launched the OH02B square two-megapixel (1,500 MP x 1,500 MP) resolution image sensor, designed for both reusable and disposable endoscopes.
  • January 2021: Steris entered into an agreement to acquire Cantel through its U.S. subsidiary, in a cash and stock transaction valued at USD 84.66 per Cantel common share.
  • January 2022: IMV Technologies acquired VES Custom Optics (VESCO) based in L’Aigle, France.

Key Players of Veterinary Endoscopes Industry:

  • Steris
  • MDS Incorporated
  • Firefly Global
  • eKuore
  • KARL STORZ SE & Co. KG
  • Advanced Monitors Corporation
  • Dr. Fritz Endoscopes GmbH
  • Zhuhai Seesheen Medical Technology Co., Ltd.
  • Biovision Veterinary Endoscopy, LLC
  • Eickemeyer

Key Segments of Veterinary Endoscopes Industry:

By Type:

In terms of type, the industry is divided into rigid, flexible, and other types.

By Animal:

The industry is classified by animal into large animals and small animals.

By Application:

By Application, the industry is bifurcated into surgical/ interventional and diagnostic.

By Procedure:

The industry is classified by procedure into arthroscopy, respiratory endoscopy, gastrointestinal endoscopy, urinary & genital tract endoscopy, abdominal endoscopy, ENT endoscopy, and other procedure types.

By Region:

Key countries of North America, Latin America, East Asia, South Asia, Western Europe, Eastern Europe, and Middle East and Africa (MEA), have been covered in the report.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Surgical Drapes Market Set to Reach USD 2.1 Billion by 2033

The global surgical drapes market is poised for significant growth, with projected sales expected to reach USD 2.1 billion by the end of 2033, according to a recent study by Future Market Insights. The market, currently valued at USD 1.4 billion in 2023, is anticipated to expand at a Compound Annual Growth Rate (CAGR) of 4.2% over the next decade.

A primary driver behind this growth is the increasing prevalence of chronic diseases, which has led to a rise in the number of surgical interventions worldwide. In the United States, for example, the American Heart Association reports that over 130 million people, or 45.1% of the adult population, will be affected by cardiovascular diseases by 2035. Additionally, heart disease remains a leading cause of death, claiming approximately 655,000 lives annually according to the Centers for Disease Control and Prevention (CDC).

The rise in chronic illnesses, including cardiovascular, respiratory, and metabolic conditions, has directly contributed to a surge in hospitalizations and surgical procedures, thereby driving demand for surgical drapes. The CDC also notes that 6 out of 10 Americans suffer from at least one chronic condition, with 4 out of 10 affected by two or more, further emphasizing the growing need for surgical care.

North America: A Key Growth Region

North America, particularly the United States, is expected to be a significant growth region for the surgical drapes market. Factors such as a well-established healthcare infrastructure, a high volume of surgical procedures, and increasing concerns about surgical site infections are fueling demand in the region. In the U.S. alone, approximately 27 million surgical procedures are performed annually, with up to 5% of these operations resulting in surgical site infections. This underscores the critical importance of stringent infection control measures, including the widespread use of surgical drapes.

Focus on Infection Control and Healthcare Expenditures

The growth of the surgical drapes market is not only linked to the rising burden of chronic diseases but also to the increasing emphasis on infection control protocols in healthcare settings. A spokesperson from Future Market Insights commented, “As healthcare expenditures continue to rise, there is an escalating demand for high-quality surgical drapes, particularly in regions with advanced healthcare infrastructure. The need for effective infection prevention measures in operating rooms has never been more urgent.”

As healthcare providers across the globe place a greater focus on maintaining stringent infection control standards, the demand for advanced surgical drapes is expected to rise, positioning the market for steady growth in the coming years.

With a positive outlook for the next decade, the global surgical drapes market is set to play a vital role in supporting the global healthcare system’s efforts to reduce surgical site infections and improve patient outcomes.

Several factors contribute to the growth and evolution of the surgical drapes industry:

  • With an increasing number of surgeries globally, there’s a higher demand for surgical drapes. Technological advancements have made various procedures more accessible, leading to an upsurge in surgeries, especially in emerging economies.
  • Healthcare-associated infections (HAIs) are a significant concern. Surgical drapes play a crucial role in preventing cross-contamination and reducing the risk of infections during procedures, thus driving their demand.
  • Regulatory bodies and healthcare standards across different regions mandate the use of surgical drapes to maintain hygiene standards, contributing to the industry’s growth.
  • Innovations in materials used for surgical drapes, such as non-woven fabrics, are enhancing their effectiveness in preventing infections, improving draping techniques, and increasing comfort for patients and healthcare professionals.

Increased Interest in Surgical Drapes: Explore Our Detailed Report for Key Trends and Insights!

Competitive Landscape:

The key players in the global Surgical Drapes market are 3M, Steris, Cardinal Health, Paul Hartmann AG, and Mölnlycke Health Care.

  • In July 2021, Thermo Fisher Scientific, a global leader in science services, entered into an alliance with Ortho Clinical Diagnostics to develop and distribute LabLink xL Quality Control Software and Thermo Scientific MAS Quality Standards which can be used with VITROS analyzers.
  • In July 2020, EDM Medical Solutions introduced CT scanner drapes, with the goal of decreasing infection spread in the medical setting.
  • In April 2020, Medline Europe issued its COVID-19 inventory update, stating that they are committed to maintaining the supply of PPE and other important medical apparel and supplies for its clients as much as possible, as well as ensuring that they are distributed fairly.

Segments Covered in Surgical Drapes Market Analysis:

By Type:

  • Reusable
  • Disposable

By Risk Type:

  • Minimal (AAMI Level 1)
  • Low (AAMI Level 2)
  • Moderate (AAMI Level 3)
  • High (AAMI Level 4)

By End-Use:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Other End-uses

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Protective Mask Market Set to Surge with a Projected CAGR of 34.5% by 2032

The global protective mask market is poised for remarkable growth, with a projected compound annual growth rate (CAGR) of 34.5% from 2022 to 2032, according to a recent market report. The surge in demand is being driven by heightened awareness of respiratory health, increasing industrial safety regulations, and ongoing global health concerns, positioning protective masks as essential safety gear across healthcare, industrial, and public sectors.

Protective masks are crucial in safeguarding against airborne particles, infectious agents, and pollutants, playing an increasingly vital role in maintaining public health. Advancements in material science, cutting-edge filtration technologies, and ergonomic design innovations are shaping the market’s dynamic landscape. These developments aim to improve user comfort and mask performance, ensuring optimal protection without compromising convenience.

A growing emphasis on sustainability and adherence to global regulatory standards is further solidifying the market’s expansion. Key players in the industry are investing heavily in research, development, and production capabilities, ensuring that the market is ready to meet rising demand and consumer expectations.

Looking ahead, leading companies are expected to pursue strategic partnerships, diversify their product portfolios, and expand into new geographic regions to meet the evolving needs of global consumers. The growing focus on respiratory health, safety, and sustainability ensures that the protective mask market will continue to thrive, offering significant growth potential for businesses and key industry players.

Key Takeaways: Protective Mask Market Growth

  • The global protective mask market is expected to see significant growth at a CAGR of 34.5% between 2022 and 2032.
  • Asia Pacific is projected to be the fastest-growing region due to factors like:
    • Densely populated countries like China and India driving mask usage.
    • Strong presence of mask manufacturers in the region.
  • Increased government and NGO recommendations for masks, particularly in emerging economies facing new waves of illnesses, will boost demand.
  • Stringent guidelines from WHO and other organizations benefit established and new players in the market.
  • N95 respirator production is likely to expand due to their high effectiveness, with rising demand from North America and Western Europe.

“With a projected CAGR of 34.5% over the next decade, the global protective mask market presents a major growth opportunity for stakeholders,” stated the report from Future Market Insights (FMI). “The expanding demand emphasizes the critical role protective masks play in public health, driving further investment in technological advancements and production capacity.”

High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!

Competitive Landscape of the Protective Mask Market

Leading companies in the protective mask market are employing various strategies to increase their market share and revenue. In response to the COVID-19 pandemic, many businesses have focused on scaling up the production of face masks specifically designed to prevent coronavirus transmission.

To maintain a competitive edge, major players are investing in research and development, enhancing product quality, and incorporating new features. Strategic collaborations are also being pursued to advance R&D capabilities further. Global demand and consumption for face masks are expected to grow in the coming years, driven by product innovation, market expansion initiatives, and increased consumer awareness. Companies are actively broadening their service offerings and consistently launching new products to meet this rising demand.

Recent Industry Developments:

  • Angelini Group initiated large-scale production of surgical masks in Italy in September 2020, establishing four fully automated lines dedicated to COVID-19 prevention devices at Luxottica’s production center. This expanded production capacity strengthens Angelini’s market position and is expected to significantly boost revenue from masks and respirators.
  • In May 2020, Honeywell announced an expansion of its mask production line in the United Kingdom, pledging to produce and supply approximately 4.5 million face masks monthly to the UK government. This initiative is part of a broader effort to address the UK’s shortage of protective masks and enhance Honeywell’s manufacturing capacity and market reach.

Key Players:

  • 3M
  • BSN Medical
  • Honeywell
  • Coltene
  • Cardinal Health
  • Dentsply Sirona

Key Market Segments:

By Material Type:

  • Polypropylene (PP)
  • Polyurethane
  • Polyester
  • Cotton
  • Others
    • Flexible PVC
    • PET
    • Rubber
    • Silicon

By Type:

  • Surgical
    • ASTM 1
    • ASTM 2
    • ASTM 3
  • Respirator
    • N-Series
    • R-Series
    • P-Series
  • Procedure
  • Others
    • Dust mask
    • Fashion mask
    • PITTA mask

By Nature:

  • Disposable
  • Reusable

By End Use:

  • Hospitals & Clinics
  • Industrial & Institutional
  • Personal/Individual Protection

By Distribution Channel:

  • Pharmacy & Drug Stores
  • Supermarket & Hypermarket
  • Specialty Stores
  • E-commerce

By Region:

  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • South America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Egg-Free Mayonnaise Market to Surpass USD 7.9 Billion by 2033 – FMI Analysis

Egg-Free Mayonnaise Market

The egg-free mayonnaise market size is projected to be valued at USD 4,315.4 million in 2023 and is expected to rise to USD 7,988.2 million by 2033. The sales of egg-free mayonnaise are expected to grow at a significant CAGR of 6.4% during the forecast period.

As more consumers embrace a vegan diet for reasons such as animal welfare, environmental sustainability, or health benefits, the egg-free mayonnaise market is experiencing a surge in innovative products with broad applications across popular food items.

Egg-free mayonnaise provides similar vitamins, proteins, and carbohydrates as dairy cheese, while also containing considerably less fat. Additionally, adopting a vegan diet has been shown to have a positive impact on health.

Millennials in particular are becoming more accepting of veganism, which has sparked industry growth. Due to increased public awareness of animal cruelty and the negative environmental effects of the dairy industry, consumers are increasingly selecting products that are made from plants.

Egg-free mayonnaise often contains less fat and is gluten-free than normal mayonnaise. One of the main factors driving the market expansion is the huge increase in the consumption of ready-to-eat (RTE) packaged vegan food and drinks as well as gluten-free and plant-based diets.

Cheese, mint, lime, BBQ, chipotle, and tandoori flavors are being introduced by product manufacturers. Given the growing popularity of veganism and vegetarian diets, they are also focusing on launching vegan, organic, and egg-free variants.

The expansion of organized distribution channels such as hypermarkets, supermarkets, convenience stores, grocery stores, and online shopping applications is providing industry players with lucrative growth opportunities.

In the upcoming years, it is anticipated that protracted promotional campaigns and celebrity endorsements by product manufacturers on social media platforms is likely to have a positive impact on egg-free mayonnaise sales.

Key Takeaways from the Egg-Free Mayonnaise Market

  • From 2023 to 2033, China is anticipated to experience the fastest CAGR of 7.1%. In the approaching years, it is anticipated that the rising demand for plant-based bakery and confectionary products in the region would drive the sale of goods.
  • Supermarkets and hypermarkets, among other distribution channels, are expected to grow significantly and capture a commanding market share of 46.3% due to their presentation, availability of a wide variety on the shelves, and ease of access to consumers. The discounts provided by supermarkets and hypermarkets are expected to boost sales of egg-free mayonnaise through this channel.
  • Due to a larger consumer base and more retail vegan outlets than any other region, the US is anticipated to contribute a significant revenue share of US$ 1,532.0 in the egg-free mayonnaise market. Several new regional companies are entering the market, each with their own unique flavor of egg-free vegan mayonnaise.
  • From 2022 to 2030, the HoReca end-use segment is anticipated to experience the fastest CAGR of 4.5%. As flexitarian and vegan diets are becoming more and more popular, many restaurants, fast food chains, and casual dining establishments have started adding plant-based items and drinks to their menus.

Competitive Landscape

The global egg-free mayonnaise market is highly fragmented, with numerous vegan mayonnaise brands present. To increase product penetration, the companies invest heavily in product launches, distribution channels, and marketing strategies. They release products made from a variety of ingredients and for a variety of purposes, such as sandwich spread, nachos dipping, and so on. Furthermore, competitive strategies such as partnerships, mergers, acquisitions, joint ventures, and so on are prevalent in this market.

Latest Developments

Press’d Sandwich Shop in Canada announced the launch of two meat-free menu items using Gardein Chick’n in December 2020. The California Vegan and the Blazing Vegan are two of the inventive sandwich options, both of which include vegan mayo and vegan cheddar cheese.

Access the full report for detailed market trends. https://www.futuremarketinsights.com/reports/egg-free-mayonnaise-market

Key Segments Covered in the Egg-Free Mayonnaise Market Report

By Nature:

  • Organic
  • Conventional

By End User:

  • HoReCa
  • Food Processors
  • Household (Retail)

By Distribution Channel:

  • Direct
  • Indirect
    • Hypermarket/ Supermarket
    • Food and Drink Specialty Stores
    • Convenience Store
    • Discount Store
    • Online Retail

By Price Range:

  • Economy
  • Premium

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube